Abstract
Human mast cells are well known to produce a serine protease, tryptase, which appears to play a pathogenic role in various skin inflammations. It was previously reported that a rat homologue of bikunin may inhibit tryptase activity. Various type of cells (i.e. keratinocytes) are able to produce this protein inhibitor, it still remains unclear if bikunin is present in dermal inflammatory milieu, in which mast cells, through secretion of tryptase, play an inflammatory role. Therefore, the purpose of the present study was to exploit expression and production of bikunin in dermis and dermal constituents. We first compared the dermal mast cells in psoriatic lesions with those in lesional skin of atopic dermatitis or of chronic eczema by use of immunoelectron microscopy and immunohistochemical analyses using antibodies to bikunin and tryptase. Then, we tested what kinds of cytokines may regulate the de novo synthesis of bikunin. To do so, RNA was extracted from a human mastocytic cell line, HMC-1, reverse-transcribed, and semiquantitative RT-PCR was performed using primers specific for bikunin. With immunoelectron microscopy, bikunin was found to localize on the cell membrane, while tryptase was in the secretary granules of the mast cells. In psoriatic lesions, around 70% of dermal mast cells were positive for both tryptase and bikunin, and the remaining was mostly positive for tryptase, but the expression of bikunin was under the detection limit of the experimental setting. This observation was seen in only psoriatic lesions, even in almost cured lesions, while in atopic dermatitis or chronic eczema only mast cells doubly positive for bikuin and tryptase were seen. In HMC-1, bikunin was constitutively expressed at an mRNA level, which was upregulated by stimulation with interleukine-4, but was suppressed by interferon-γ. Bearing in mind the concept that in psoriasis local cytokine milieu is shifted toward a Th1 pattern (predominant secretion of interferon-γ), tryptase-positive, bikunin-negative mast cells may be induced.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Butterfield JH, Weiler D, Dewald G, Gleich GJ (1988) Establishment of an immature mast cell line from a patient with mast cell leukemia. Leuk Res 12:345–355
Christophers E (2001) Psoriasis-epidermology and clinical spectrum. Clin Exp Dermatol 26:314–320
Cui CY, Aragane Y, Maeda A, Piao YL, Takahashi M, Kim LH, Tezuka T (1999) Bikunin, a serine protease inhibitor, is present on the cell boundary of epidermis. J Invest Dermatol 113:182–188
Furue M (1994) Atopic dermatitis-immunological abnormality and its lacking control. J Dermatol Sci 7:159–168
Gueston JL, Ternynck T, Avrameras S (1979) The use of avidin–biotin interaction in immunoenzymatic techniques. Histochem Cytochem 27:1131–1139
Harvima TT, Schwartz LB (1992) Mast cell products in the monitoring of allergic inflammation. In: Miyamoto T, Okuda M (eds) Progress in allergy and clinical immunology 2. Hogrefe and Huber, Seattle, pp 184–190
Harvima IT, Naukkarinen A, Harvima RJ, Aalto ML, Neittaanmaki H, Horsmanheimo M (1990) Quantitative enzyme-histochemical analysis of tryptase- and chymase-containing mast cells in psoriatic skin. Arch Dermatol Res 282:428–433
Ide H, Itoh H, Yoshida E, Kobayashi T, Tomita M, Maruyama H, Osada Y, Nakahata T, Nawa Y (1999) Immunohistochemical demonstration of inter-α-trypsin inhibitor light chain (bikunin) in human mast cells. Cell Tissue Res 297:149–154
Irani AA, Schechter NM, Craig SS, DeBlois G, Schwartz LB (1986) Two type of human mast cells that have distinct neutral protease composition. Proc Natl Acad Sci USA 83:4464–4468
Irani AA, Bradford TR, Kepley CL, Schechter NM, Schwartz LB (1989) Detection of MCT and MCTC types of human mast cells by immunohitochemistry using new monoclonal anti-tryptase and anti-chymase antibodies. J Histochem Cytochem 37:1509–1515
Isogai R, Matsukura A, Aragane Y, Maeda A, Matsukura M, Yudate T, Sugahara K, Takahasi M, Aisu K, Tezuka T (2002) Quantitative analysis of bikunin-laden mast cells in infantile atopic skin with follicular papules and atopic chronic skin lesions. Arch Dermatol Res 294:387–392
Kobayashi H, Gotoh J, Fujii M, Terao T (1994) Characterization of the cellular binding site for the urinary trypsin inhibitor. J Biol Chem 269:20642–20647
Kusuda S, Cui CY, Takahashi M, Tezuka T (1998) Localization of sphingomyelinase in lesional skin of atopic dermatitis patients. J Invest Dermatol 111:773–738
Nickoloff BJ (2000) Characterization of lymphocyte-dependent angiogenesis using a SCID mouse: human skin model of psoriasis. J Investig Dermatol Symp Proc 5:67–73
Nickoloff BJ, Wrone-Smith T (1999) Injection of pre-psoriatic skin with CD4+ T cells induces psoriasis. Am J Pathol 155:145–158
Nickoloff BJ, Schroder JM, von den Driesch P, Raychaudhuri SP, Farber EM, Boehncke WH, Morhenn VB, Rosenberg EW, Schon MP, Holick MF (2000) Is psoriasis a T-cell disease? Exp Dermatol 9:359–375
Ohtsu H, Kuramasu A, Tanaka S, Terui T, Hirasawa N, Hara M, Makabe-Kobayashi Y, Yamada N, Yanai K, Sakurai E, Okada M, Ohuchi K, Ichikawa A, Nagy A, Watanabe T (2002) Plasma extravasation induced by dietary supplemented histidine-free mice. Eur J Immunol 32:1689–1708
Pugia MJ, Lott JA (2005) Pathophysiology and diagnostic value of urinary trypsin inhibitors. Clin Chem Lab Med 43:1–6
Raychaudhuri SP, Dutt S, Raychaudhuri SK, Sanyal M, Farber EM (2001) Severe combined immunodeficiency mouse–human skin chimeras: a unique animal model for the study of psoriasis and cutaneous inflammation. Br J Dermatol 144:931–939
Schwartz LB, Kawahara MS, Hugli TE, Vik D, Fearon DT, Austen KF (1983) Generation of C3a anaphylatoxin from human C3 by human mast cell tryptase. J Immunol 130:1891–1895
Steinhoff M, Corvera CU, Thomas MS, Kong W, MacAlpine BE, Caughey GH, Ansel JC, Bunnett NW (1999) Proteinase-activated receptor-2 in human skin. Tissue distribution and activation of keratinocytes by mast cell tryptase. Exp Dermatol 8:282–294
Toruniowa B, Jablonska S (1988) Mast cells in the initial stages of psoriasis. Arch Dermatol Res 280:189–193
Toyry S, Fraki J, Tammi R (1988) Mast cell density in psoriatic skin. The effect of PUVA and corticosteroid therapy. Arch Dermatol Res 280:282–285
Wakita H, Furukawa F, Takigawa M (1977) Thrombin and trypsin stimulate granulocyte-macrophage colony-stimulating factor and interleukin-6 gene expression in cultured normal human keratinocytes. Proc Assoc Am Phys 109:190–207
Yamazaki F, Aragane Y, Maeda A, Matsushita K, Ueno K, Yudate T, Kawada A, Tezuka T (2002) Overactivation of IL-4-induced activator protein-1 in atopic dermatitis. J Dermatol Sci 28:227–233
Yetr H, Gebhard W (1990) Structure of human α1-microglubulin-bikunin gene. Biol Chem Hoppe Seyler 371:1185–1196
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ashenagar, M.S., Sugihara, K., Maeda, A. et al. The presence of tryptase-positive and bikunin-negative mast cells in psoriatic skin lesions. Arch Dermatol Res 298, 421–426 (2007). https://doi.org/10.1007/s00403-006-0704-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00403-006-0704-y